- Home
- GDTC vs SNES Comparison
GDTC vs SNES Comparison
Compare GDTC & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- SNES
- Stock Information
- Founded
- GDTC 2018
- SNES 2004
- Country
- GDTC Singapore
- SNES United States
- Employees
- GDTC N/A
- SNES N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- GDTC Health Care
- SNES Industrials
- Exchange
- GDTC Nasdaq
- SNES Nasdaq
- Market Cap
- GDTC 21.5M
- SNES 21.0M
- IPO Year
- GDTC 2023
- SNES 2016
- Fundamental
- Price
- GDTC $1.77
- SNES $4.59
- Analyst Decision
- GDTC Buy
- SNES Strong Buy
- Analyst Count
- GDTC 1
- SNES 1
- Target Price
- GDTC $5.00
- SNES $10.00
- AVG Volume (30 Days)
- GDTC 17.4K
- SNES 195.9K
- Earning Date
- GDTC 01-01-0001
- SNES 08-07-2025
- Dividend Yield
- GDTC N/A
- SNES N/A
- EPS Growth
- GDTC N/A
- SNES N/A
- EPS
- GDTC N/A
- SNES N/A
- Revenue
- GDTC $368,838.00
- SNES $2,093,000.00
- Revenue This Year
- GDTC $5.37
- SNES $130.53
- Revenue Next Year
- GDTC N/A
- SNES $80.00
- P/E Ratio
- GDTC N/A
- SNES N/A
- Revenue Growth
- GDTC N/A
- SNES 36.89
- 52 Week Low
- GDTC $1.20
- SNES $1.30
- 52 Week High
- GDTC $4.05
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- GDTC 34.10
- SNES 45.55
- Support Level
- GDTC $1.79
- SNES $4.30
- Resistance Level
- GDTC $1.88
- SNES $6.24
- Average True Range (ATR)
- GDTC 0.06
- SNES 0.42
- MACD
- GDTC -0.00
- SNES -0.16
- Stochastic Oscillator
- GDTC 4.88
- SNES 14.90
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.